Bank of Japan Governor Kazuo Ueda said on Wednesday the central bank will conduct monetary policy bearing in mind there are ...

Black grouse and caviar helped Stalin get much of what he wanted, but his Red Army counted for more, says a notable historian ...

Great Britain will face a relegation play-off in the Davis Cup after their makeshift team failed to make the cut and were beaten 3-2 by Japan. While Jacob Fearnley gave the side hope, this was quickly ...

For more than two years, the bulls have been running wild on Wall Street. In 2024, the ageless Dow Jones Industrial Average (DJINDICES: ^DJI), broad-based S&P 500 (SNPINDEX: ^GSPC), and innovation ...

This marked the first time since the Great Depression that M2 dropped by at least 2% on a year-over-year basis. Though I'll address the correlative implications of this historic drop-off in M2 in ...

Fresh from his run to the third round at the Australian Open, Scotland's Jacob Fearnley levels Great Britain's Davis Cup first-round qualifying tie with Japan after beating former US Open finalist ...

“I am feeling great, I was extremely nervous before the match, as to be expected, it is my first Davis Cup match and playing such a great player I knew I had to play good,” Fearnley said.

Jeff Winograd, who's lived with depression for more than 25 years, says ketamine treatment saved his life. Jeff Winograd couldn’t get off his couch. He’d hit rock bottom with the depression he ...

Jacob Fearnley enjoyed an impressive David Cup debut (Jordan Pettitt/PA) Jacob Fearnley delivered an impressive Davis Cup debut as he levelled Great Britain’s tie with Japan after the opening day.

Great Britain's Davis Cup qualifying tie against Japan is a "great opportunity" for others in the absence of Jack Draper and Cameron Norrie, says captain Leon Smith. World number 77 Jacob Fearnley ...

Seasonal affective disorder (SAD), or seasonal depression, is more than just the ... meditating and connecting with loved ones are [also] great ways to increase emotional well-being and decrease ...

In 2020, Neurocrine Biosciences and Takeda entered into a strategic collaboration to develop and commercialize compounds in depression and schizophrenia, including an exclusive license to both ...